Protocol Ledger

NCT04965298 · Phase III · RECRUITING

Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole

Interventional Phase III clinical trial protocol NCT04965298 sponsored by Norfolk and Norwich University Hospitals NHS Foundation Trust in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-06-16 Enrollment: 298 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04965298
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)298 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04965298
Protocol FieldVerified Registry Value
NCT IdentifierNCT04965298
Consolidated Lead SponsorNorfolk and Norwich University Hospitals NHS Foundation Trust
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment298 participants (ESTIMATED)
Registered Start Date2021-06-16
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04965298
Hospital Research SiteLocationSite Profile
University Hospitals Birmingham NHS Foundation TrustBirmingham, United KingdomOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI